Peptide-drug conjugate PEN-221 demonstrates efficacy in patients with GI neuroendocrine tumors June 10, 2021
Cardiff Oncology initiates phase II trial of onvansertib for metastatic pancreatic cancer June 9, 2021
DZD-9008 shows antitumor activity in NSCLC patients with EGFR exon20 insertion mutations June 9, 2021
Phase Ib data indicate ST-617 can reduce severity of OM in patients receiving chemoradiation June 9, 2021
Selpercatinib shows promising safety and efficacy in RET-altered solid tumors in pediatric patients June 8, 2021
RSS